Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-300
Closed -$12K 1627
2016
Q3
$12K Hold
300
﹤0.01% 1073
2016
Q2
$10K Hold
300
﹤0.01% 1094
2016
Q1
$10K Hold
300
﹤0.01% 1050
2015
Q4
$12K Sell
300
-300
-50% -$11.7K ﹤0.01% 1030
2015
Q3
$23K Hold
600
0.01% 852
2015
Q2
$23K Hold
600
0.01% 936
2015
Q1
$20K Sell
600
-250
-29% -$7.67K 0.01% 985
2014
Q4
$23K Hold
850
﹤0.01% 1172
2014
Q3
$21K Hold
850
﹤0.01% 1259
2014
Q2
$22K Hold
850
﹤0.01% 1236
2014
Q1
$18K Sell
850
-50
-6% -$1.08K ﹤0.01% 1285
2013
Q4
$20K Sell
900
-5
-0.6% -$110 ﹤0.01% 1345
2013
Q3
$19K Buy
905
+55
+6% +$1.17K ﹤0.01% 1298
2013
Q2
$16K Buy
+850
New +$17.8K ﹤0.01% 1290

Other funds holding HOLX

WFG Advisors's HOLX Position: Q4 2016 in Review

WFG Advisors sold out of Hologic (HOLX) in Q4 2016, closing a stake of 300 shares — an estimated $12K sold.

WFG Advisors first reported a position in HOLX in Q2 2013 and held it in 14 quarters. The position peaked at $23K in Q3 2015. 512 funds tracked by Wall St. Rank hold HOLX as of Q4 2016.

  • WFG Advisors reported no remaining Hologic position as of Q4 2016 after selling out during the quarter.
  • WFG Advisors sold 300 Hologic shares in Q4 2016, an estimated $12K.
  • WFG Advisors first reported a position in Hologic in Q2 2013 and held it in 14 quarters.
  • WFG Advisors's Hologic position peaked at $23K in Q3 2015.
  • 512 funds tracked by Wall St. Rank held Hologic as of Q4 2016.

Based on WFG Advisors's 13F filing for Q4 2016, filed 1 Mar 2017.